Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: A prospective study

American Journal of Surgery

Volumn 207, Issue 6, 2014, Pages 824-831

  Madbouly, Khaled M ^a   Abbas, Khaled S ^a   Hussein, Ahmed M ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Metastatic lymph node ratio; Rectal cancer; Recurrence

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CARCINOMA; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUMOR INVASION;

METASTATIC LYMPH NODE RATIO; RECTAL CANCER; RECURRENCE;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY; COLONOSCOPY; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 84901838741     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2013.07.022     Document Type: Article

References (30)

1. J. Kehoe, and V.P. Khatri Staging and prognosis of colon cancer Surg Oncol Clin N Am 15 2006 129 146
2. E.J. Morris, N.J. Maughan, and D. Forman et al. Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology Gut 56 2007 1419 1425
3. C.C. Compton, L.P. Fielding, and L.J. Burgart et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 2000 979 994
4. Y.J. Park, E.G. Youk, and H.S. Choi et al. Experience of 1446 rectal cancer patients in Korea and analysis of prognostic factors Int J Colorectal Dis 14 1999 101 106
5. R. Harisi, Z. Schaff, and L. Flautner et al. Evaluation and comparison of the clinical, surgical and pathological TNM staging of colorectal cancer Hepatogastroenterology 55 2008 66 72
6. F.L. Greene Current TNM staging of colorectal cancer Lancet Oncol 8 2007 572 573
7. K.H. Kim, S.S. Yang, and Y.S. Yoon et al. Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in Korea Colorectal Dis 13 2011 e220 e226
8. F. Peschaud, S. Benoist, and C. Julie et al. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer Ann Surg 248 2008 1067 1073
9. R. Rosenberg, J. Friederichs, and T. Schuster et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period Ann Surg 248 2008 968 978
10. H. Wang, B. Safar, and S. Wexner et al. Lymph node harvest after proctectomy for invasive rectal adenocarcinoma following neoadjuvant therapy: does the same standard apply? Dis Colon Rectum 52 2009 549 557
11. H. Kobayashi, H. Mochizuki, and T. Kato et al. Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study Int J Colorectal Dis 26 2011 891 896
12. Y.S. Kim, J.H. Kim, and S.M. Yoon et al. Lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy Int J Radiat Oncol Biol Phys 74 2009 796 802
13. D.G. Priolli, I.A. Cardinalli, and J.A. Pereira et al. Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients Tech Coloproctol 13 2009 113 121
14. J.W. Dekker, K.C. Peeters, and H. Putter et al. Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification Eur J Surg Oncol 36 2011 1180 1186
15. D.K. Dhar, H. Yoshimura, and N. Kinukawa et al. Metastatic lymph node size and colorectal cancer prognosis J Am Coll Surg 200 2005 20 28
16. S.B. Edge, and C.C. Compton The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 17 2011 1471 1474
17. D.C. Damin, M.A. Rosito, and P.C. Contu et al. Lymph node retrieval after preoperative chemoradiotherapy for rectal cancer J Gastrointest Surg 16 2011 1573 1580
18. S.G. de la Fuente, R.J. Manson, and K.A. Ludwig et al. Neoadjuvant CRT for rectal cancer reduces lymph node harvest in proctectomy specimens J Gastrointest Surg 13 2009 269 274
19. J. Kang, H. Hur, and B.S. Min et al. Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative CRT J Surg Oncol 104 2011 53 58
20. D. Edler, K. Ohrling, and M. Hallstrom et al. The number of analyzed lymph nodes - a prognostic factor in colorectal cancer Acta Oncol 46 2007 975 981
21. E.A. Manilich, R.P. Kiran, and T. Radivoyevitch et al. A novel data-driven prognostic model for staging of colorectal cancer J Am Coll Surg 213 2011 579 588
22. M.F. Osti, M. Valeriani, and L. Masoni et al. Neoadjuvant CRT for locally advanced carcinoma of the rectum Tumori 90 2004 303 309
23. N.N. Baxter, A.M. Morris, and D.A. Rothenberger et al. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis Int J Radiat Oncol Biol Phys 61 2005 426 431
24. R.E. Wijesuriya, K.I. Deen, and J. Hewavisenthi et al. Neoadjuvant therapy for rectal cancer down-stages the tumor but reduces lymph node harvest significantly Surg Today 35 2005 442 445
25. C.L. Klos, L.G. Bordeianou, and P. Sylla et al. The prognostic value of lymph node ratio after neoadjuvant CRT and rectal cancer surgery Dis Colon Rectum 54 2011 171 175
26. P. Taflampas, M. Christodoulakis, and S. Gourtsoyianni et al. The effect of preoperative chemoradiotherapy on lymph node harvest after total mesorectal excision for rectal cancer Dis Colon Rectum 52 2009 1470 1474
27. T. Leibold, J. Shia, and L. Ruo et al. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy J Clin Oncol 26 2008 2106 2111
28. W. Ceelen, Y. Van Nieuwenhove, and P. Pattyn Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review Ann Surg Oncol 17 2010 2847 2855
29. L. Collette, J.F. Bosset, and M. den Dulk et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group J Clin Oncol 25 2007 4379 4386
30. K. Bujko, R. Glynne-Jones, and M. Bujko Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials Ann Oncol 21 2010 1743 1750